JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details

339 Tue, 8/2/2011, 10:30 AM - 12:20 PM CC-C222
Statistical Considerations in the Analysis of Progressive Free Survival — Topic Contributed Papers
Biopharmaceutical Section , Section for Statistical Programmers and Analysts , Section on Statistics in Epidemiology
Organizer(s): Jing Xu, Millennium Pharmaceuticals
Chair(s): Satrajit Roychoudhury, Novartis
10:35 AM Predicting Analysis Time in Event-Driven Clinical Trials with Event-Reporting Lag Jianming Wang, Novartis Oncology ; Chunlei Ke, Amgen Inc. ; Qi Jiang, Amgen Inc. ; Charlie Zhang, Exelixis ; Steve Snapinn, Amgen Inc.
10:55 AM The Effect of Periodic Follow-Up: Design and Analysis of Progression-Free Survival Data Zhigang Zhang, MSKCC
11:15 AM Some Practical Issues in PFS Analysis from Industry Perspective — Jingyuan Wang, Millennium Pharmaceuticals ; Connie Lee, Millennium Pharmaceuticals ; Jing Xu, Millennium Pharmaceuticals ; Yuanjun Shi, Millennium Pharmaceuticals
11:35 AM Regulatory Considerations in the Evaluation of Progression-Free Survival Rajeshwari Sridhara, U.S. Food and Drug Administration
11:55 AM Issues in the Analysis of Progression-Free Survival from a Cancer Clinical Trial Dianne M. Finkelstein, Massachusetts General Hospital/Harvard School of Public Health
12:15 PM Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.